About Accepted Preprints
Accepted Preprints is a new, improved service where authors' manuscripts are posted online immediately upon acceptance, prior to copy editing, page layout and proofing. This places them in the public domain well in advance of final publication.
Upon publication of the definitive formatted version, they are removed from the Accepted Preprints list and placed in the table of contents for the relevant issue.
Most
-
Viewed
- Association of Hashimoto's thyroiditis with thyroid cancer
- p53 and breast cancer, an update
- Insulin resistance and cancer: the role of insulin and IGFs
- Progesterone metabolites in breast cancer
- The emerging roles of DNA methylation in the clinical management of prostate cancer
-
Cited
- Fibroblast growth factors, their receptors and signaling
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
- BRAF mutation in thyroid cancer
- mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
- Discovery of a novel Raf kinase inhibitor
